Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Masaoki Ito

Integrin-Linked Kinase (ILK) and SRC Homology 2 Domain-Containing Phosphatase 2 (SHP2): Novel Targets in EGFR-mutation Positive Non-Small Cell Lung Cancer (NSCLC)

EBioMedicine

English

Metachronous Lung Cancer Post Pleurectomy/Decortication

Annals of Thoracic Surgery

Respiratory Medicine

Pulmonary

Cardiovascular Medicine

Surgery

Cardiology

2019

English

Related publications

Integrin-Linked Kinase (ILK)

Science-Business eXchange

2011

English

A Novel SRC Homology 2 Domain-Containing Molecule, SRC-Like Adapter Protein-2 (SLAP-2), Which Negatively Regulates T Cell Receptor Signaling

Journal of Biological Chemistry

English

SRC Homology 2 Domain–containing Inositol 5-Phosphatase 1 Deficiency Leads to a Spontaneous Allergic Inflammation in the Murine Lung

Journal of Allergy and Clinical Immunology

Allergy

Immunology

2007

English

Differential Regulation of B Cell Development, Activation, and Death by the SRC Homology 2 Domain–Containing 5′ Inositol Phosphatase (Ship)

Journal of Experimental Medicine

English

Third Generation EGFR TKI Landscape for Metastatic EGFR Mutant Non-Small Cell Lung Cancer (NSCLC)

Expert Review of Anticancer Therapy

Oncology

Pharmacology

2019

English

Cost‐Effectiveness of Osimertinib in Treating Newly Diagnosed, Advanced EGFR‐Mutation‐Positive Non‐Small Cell Lung Cancer

English

Non-Invasive Urine Testing of EGFR Activating Mutation and T790M Resistance Mutation in Non-Small Cell Lung Cancer

Experimental Hematology and Oncology

English

JCES 01.18 Uncommon Mutation Types of EGFR and Response to EGFR Tyrosine Kinase Inhibitors in Chinese Non-Small Cell Lung Cancer Patients

Journal of Thoracic Oncology

English

EGFR delE709_T710insD: A Rare but Potentially EGFR Inhibitor Responsive Mutation in Non–Small-Cell Lung Cancer

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Masaoki Ito

Integrin-Linked Kinase (ILK) and SRC Homology 2 Domain-Containing Phosphatase 2 (SHP2): Novel Targets in EGFR-mutation Positive Non-Small Cell Lung Cancer (NSCLC)

Metachronous Lung Cancer Post Pleurectomy/Decortication

Related publications

Integrin-Linked Kinase (ILK)

A Novel SRC Homology 2 Domain-Containing Molecule, SRC-Like Adapter Protein-2 (SLAP-2), Which Negatively Regulates T Cell Receptor Signaling

SRC Homology 2 Domain–containing Inositol 5-Phosphatase 1 Deficiency Leads to a Spontaneous Allergic Inflammation in the Murine Lung

Differential Regulation of B Cell Development, Activation, and Death by the SRC Homology 2 Domain–Containing 5′ Inositol Phosphatase (Ship)

Third Generation EGFR TKI Landscape for Metastatic EGFR Mutant Non-Small Cell Lung Cancer (NSCLC)

Cost‐Effectiveness of Osimertinib in Treating Newly Diagnosed, Advanced EGFR‐Mutation‐Positive Non‐Small Cell Lung Cancer

Non-Invasive Urine Testing of EGFR Activating Mutation and T790M Resistance Mutation in Non-Small Cell Lung Cancer

JCES 01.18 Uncommon Mutation Types of EGFR and Response to EGFR Tyrosine Kinase Inhibitors in Chinese Non-Small Cell Lung Cancer Patients

EGFR delE709_T710insD: A Rare but Potentially EGFR Inhibitor Responsive Mutation in Non–Small-Cell Lung Cancer